Geneos Therapeutics is a Phase 2b biotherapeutics company developing DNA-based personalized immunotherapies for cancer, utilizing its proprietary GT-EPIC™ platform to create custom immunotherapeutic DNA plasmids designed to target unique tumor neoantigens
Geneos Therapeutics is a Phase 2b biotherapeutics company developing DNA-based personalized immunotherapies for cancer, utilizing its proprietary GT-EPIC™ platform to create custom immunotherapeutic DNA plasmids designed to target unique tumor neoantigens.